---
figid: PMC6498733__AJA-21-253-g001
figlink: /pmc/articles/PMC6498733/figure/F1/
number: Figure 1
caption: 'Beta-adrenergic signaling pathway in prostatic cancer. When beta-adrenergic
  receptors on prostate cancer cells are activated by epinephrine or norepinephrine,
  cellular cAMP level is increased. cAMP level in prostate cancer cells is also elevated
  by cancer treatments, such as radiation and hormonal therapies. cAMP activates PKA
  and EPAC. PKA can either directly stimulate or act through PAK4 to increase CREB
  activity. Activated PKA/CREB axis contributes to several biological processes relevant
  for cancer progression, such as (1) promoting angiogenesis through induction of
  VEGF, and repression of TSP1 and PAI2 through inducing HDAC2 and GRK3; (2) promoting
  NED, at least in part through direct induction of ENO2 as well as GRK3 that in turn
  elevates neuroendocrine markers in prostate cancer cells; (3) inhibiting apoptosis
  through CREB-induction of BCL2, and PKA-mediated phosphorylation of BAD (inhibiting)
  and AKT (activating); (4) together with EPAC, regulating cytoskeletal rearrangement
  and cellular migration through regulating ROCK activity via RhoA and PAK4. cAMP:
  cyclic adenosine monophosphate; PKA: protein kinase A; CREB: cAMP response element-binding;
  VEGF: vascular endothelial growth factor; NED: neuroendocrine differentiation; TSP1:
  thrombospondin 1; PAI2: plasminogen activator inhibitor-2; HDAC2: histone deacetylase
  2; GRK3: G-protein receptor kinase 3; BCL-2: B-cell lymphoma-2; BAD: BCL-2-associated
  death promoter.'
pmcid: PMC6498733
papertitle: Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis,
  and metastasis in prostate cancer progression.
reftext: Yicheng Zhao, et al. Asian J Androl. 2019 May-Jun;21(3):253-259.
pmc_ranked_result_index: '24270'
pathway_score: 0.9781397
filename: AJA-21-253-g001.jpg
figtitle: Beta-adrenergic signaling pathway in prostatic cancer
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6498733__AJA-21-253-g001.html
  '@type': Dataset
  description: 'Beta-adrenergic signaling pathway in prostatic cancer. When beta-adrenergic
    receptors on prostate cancer cells are activated by epinephrine or norepinephrine,
    cellular cAMP level is increased. cAMP level in prostate cancer cells is also
    elevated by cancer treatments, such as radiation and hormonal therapies. cAMP
    activates PKA and EPAC. PKA can either directly stimulate or act through PAK4
    to increase CREB activity. Activated PKA/CREB axis contributes to several biological
    processes relevant for cancer progression, such as (1) promoting angiogenesis
    through induction of VEGF, and repression of TSP1 and PAI2 through inducing HDAC2
    and GRK3; (2) promoting NED, at least in part through direct induction of ENO2
    as well as GRK3 that in turn elevates neuroendocrine markers in prostate cancer
    cells; (3) inhibiting apoptosis through CREB-induction of BCL2, and PKA-mediated
    phosphorylation of BAD (inhibiting) and AKT (activating); (4) together with EPAC,
    regulating cytoskeletal rearrangement and cellular migration through regulating
    ROCK activity via RhoA and PAK4. cAMP: cyclic adenosine monophosphate; PKA: protein
    kinase A; CREB: cAMP response element-binding; VEGF: vascular endothelial growth
    factor; NED: neuroendocrine differentiation; TSP1: thrombospondin 1; PAI2: plasminogen
    activator inhibitor-2; HDAC2: histone deacetylase 2; GRK3: G-protein receptor
    kinase 3; BCL-2: B-cell lymphoma-2; BAD: BCL-2-associated death promoter.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SERPINB2
  - ACTA2
  - ACTB
  - PAK4
  - PGF
  - ACTG2
  - AKT2
  - ACTC1
  - ACTG1
  - GRK3
  - HDAC2
  - CREB3
  - RAPGEF3
  - ATF2
  - CREM
  - CREB3L4
  - CREB1
  - CREB3L2
  - CREB3L3
  - CREB3L1
  - ATF1
  - ENO2
  - ROCK2
  - VEGFA
  - VEGFC
  - VEGFB
  - VEGFD
  - PRKACA
  - PRKACB
  - PRKACG
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - CREB5
  - ROCK1
  - AKT1
  - BAD
  - BCL2
  - AKT3
  - ACTA1
  - RHOA
  - TERF2IP
  - PRKAR2B
  - Epinephrine
  - Norepinephrine
  - CAMP
  - ATP
  - ENO2
  - Cancer
genes:
- word: PAI2
  symbol: PAI2
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINB2
  entrez: '5055'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: PAK4
  symbol: PAK4
  source: hgnc_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: GRK3
  symbol: GRK3
  source: hgnc_symbol
  hgnc_symbol: GRK3
  entrez: '157'
- word: HDAC2
  symbol: HDAC2
  source: hgnc_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: EPAC
  symbol: EPAC
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF3
  entrez: '10411'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: ENO2
  symbol: ENO2
  source: hgnc_symbol
  hgnc_symbol: ENO2
  entrez: '2026'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: Rap1
  symbol: RAP1
  source: hgnc_alias_symbol
  hgnc_symbol: TERF2IP
  entrez: '54386'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
chemicals:
- word: Epinephrine
  source: MESH
  identifier: D004837
- word: Norepinephrine
  source: MESH
  identifier: D009638
- word: CAMP
  source: MESH
  identifier: C106170
- word: ATP
  source: MESH
  identifier: D000255
- word: ENO2
  source: MESH
  identifier: C095157
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
